Zanamivir
Thông số
139110-80-8Số CAS
691-117-1Số EC
(2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acidTên IUPAC
C12H20N4O7Công thức hóa học
332.31 g/molKhối lượng phân tử
zanamivir; 139110-80-8; Relenza; GANA; 4-Guanidino-Neu5Ac2en; GG167; GG-167; GR-121167X; DTXSID0023749; GR 121167X; GANA (inhibitor); GG 167; 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid; L6O3XI777I; GR-121167; 5-Acetamido-2,6-anhydro-3,4,5-trideoxy-4-guanidino-D-glycero-D-galacto-non-2-enonic acid; DTXCID503749; CHEBI:50663; 5-(acetylamino)-2,6-anhydro-4-carbamimidamido-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid; 4-guanidino-2,4-dideoxy-2,3-didehydro-N-acetylneuraminic acid; (2R,3R,4S)-3-(acetylamino)-4-carbamimidamido-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid; (2r,3r,4s)-4-[(diaminomethylidene)amino]-3-acetamido-2-[(1r,2r)-1,2,3-trihydroxypropyl]-3,4-dihydro-2h-pyran-6-carboxylic acid; 4 Guanidino Neu5Ac2en; zanamivirum; (2R,3R,4S)-3-(acetylamino)-4-carbamimidamido-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid; (2R,3R,4S)-4-((diaminomethylidene)amino)-3-acetamido-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid; RefChem:56369; 4 Guanidino 2 Deoxy 2,3 Didehydro N Acetylneuraminic Acid; 4-guanidino-2-deoxy-2,3-didehydro-N-acetylneuraminic acid; J05AH01; Acid, 4-Guanidino-2-Deoxy-2,3-Didehydro-N-Acetylneuraminic; 2,3-didehydro-2,4-dideoxy-4-guanidinyl-N-acetylneuraminic acid; 2,3-didehydro-2,4-dideoxy-4-guanidino-N-acetyl-D-neuraminic acid; 5-acetylamino-2,6-anhydro-4-guanidino-3,4,5-trideoxy-D-galacto-non-enoic acid; 5-acetylamino-4-guanidino-6-(1,2,3-trihydroxypropyl)-5,6-dihydro-4H-pyran-2-carboxylic acid; Zanamavir; MFCD00866966; (2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid; ZMR; CHEMBL222813; C12H20N4O7; 551942-41-7; ZANAMIVIR TFA; (2R,3R,4S)-3-Acetamido-4-guanidino-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid; (2R,3R,4S)-3-acetamido-4-guanidino-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid; (2R,3R,4S)-4-Guanidino-3-(prop-1-en-2-ylamino)-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid; Relenza (TN); CAS-139110-80-8; 4-Guanidino-NeueAc2en; UNII-L6O3XI777I; Dectova; Zanamivi; Zanamivir [USAN:INN:BAN]; HSDB 7437; 2qwe; ARAIBEBZBOPLMB-UFGQHTETSA-N; NCGC00164561-01; 139110-80-8 (free base); GR121167X; Zanamivir (Relenza); Zanamivir (Standard); Zanamivir hydrate CRS; Zanamivir (Relenza)?; Relenza, GG 167; 1a4g; Zanamivir (USP/INN); ZANAMIVIR [INN]; ZANAMIVIR [MI]; Zanamivir for assay CRS; ZANAMIVIR [HSDB]; ZANAMIVIR [USAN]; ZANAMIVIR [VANDF]; ZANAMIVIR [MART.]; SCHEMBL9501; SCHEMBL9502; ZANAMIVIR [USP-RS]; ZANAMIVIR [WHO-DD]; GNA; BIDD:GT0349; BDBM4934; orb1226384; orb1305352; ZANAMIVIR [ORANGE BOOK]; Zanamivir, >=98% (HPLC); GTPL12307; ZANAMIVIR [USP MONOGRAPH]; MSK10031; Tox21_112190; BDBM50219992; BDBM50330326; EBC-26618; HY-13210R; s3007; AKOS015841013; AKOS015994539; Tox21_112190_1; BS-1017; CCG-267828; CS-0631; DB00558; MZ04270; NCGC00164561-02; NCGC00164561-08; NCGC00164561-11; (2R,3R,4S)-3-acetamido-4-((diaminomethylene)amino)-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid; (2R,3R,4S)-4-carbamimidamido-3-acetamido-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid; 5-(acetylamino)-4-{[amino(imino)methyl]amino}-2,6-anhydro-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid; HY-13210; SY102286; NS00003906; Z0023; Z0252; C08095; C72554; D00902; AB01566897_01; EN300-26991905; Q146075; BRD-K23067689-001-02-1; Zanamivir Working Standard (Secondary Reference Standard); Zanamivir, United States Pharmacopeia (USP) Reference Standard; Zanamivir for assay, EuropePharmacopoeia (EP) Reference Standard; Zanamivir for system suitability, European Pharmacopoeia (EP) Reference Standard; (2R,3R,4S)-3-(ACETYLAMINO)-4-{[AMINO(IMINO)METHYL]AMINO}-2-[(1R,2R)-1,2,3-TRIHYDROXYPROPYL]-3,4-DIHYDRO-2H-PYRAN-6-CARBOXYLIC ACID; (2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acidEE; (4S,5R,6R)-5-acetamido-4-(diaminomethyleneamino)-6-((1R,2R)-1,2,3-trihydroxypropyl)-5,6-dihydro-4H-pyran-2-carboxylic acid; (4S,5R,6R)-5-acetylamino-4-guanidino-6-((1R,2R)-1,2,3-trihydroxy-propy)-5,6-dihydro-4H-pyran-2-carboxylic acid; (4S,5R,6R)-5-acetylamino-4-guanidino-6-((1R,2R)-1,2,3-trihydroxy-propyl)-5,6-dihydro-4H-pyran-2-carboxylic acid; (4S,5R,6R)-5-Acetylamino-4-guanidino-6-((1R,3R)-1,2,3-trihydroxy-propyl)-5,6-dihydro-4H-pyran-2-carboxylic acid; (4S,5R,6R)-5-Acetylamino-4-guanidino-6-((R)-1,2,3-trihydroxy-propyl)-5,6-dihydro-4H-pyran-2-carboxylic acid; (4S,5R,6R)-5-Acetylamino-4-guanidino-6-(1,2,3-trihydroxy-propyl)-5,6-dihydro-4H-pyran-2-carboxylic acid; 4-diaminomethylamino-3-methylcarboxamido-2-(1,2,3-trihydroxypropyl)-(3R)-3,4-dihydro-2H-6-pyrancarboxylic acid(Zanamivir); 5-Acetamido-2,6-anhydro-4-(carbamimidoylamino)-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid; 5-acetamido-2,6-anhydro-4-carbamimidamido-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid; 5-Acetylamino-4-guanidino-6-(1,2,3-trihydroxy-propyl)-5,6-dihydro-4H-pyran-2-carboxylic acid; 5-Acetylamino-4-guanidino-6-(1,2,3-trihydroxy-propyl)-5,6-dihydro-4H-pyran-2-carboxylic acid(zanamivir); 5-Formylamino-4-guanidino-6-(1,2,3-trihydroxy-propyl)-5,6-dihydro-4H-pyran-2-carboxylic acid; D-glycero-D-galacto-Non-2-enonic acid, 5-(acetylamino)-4-(aminoiminomethyl)amino)-2,6-anhydro-3,4,5-trideoxy-; Zanamivir MicronizedTên gọi khác
